Lack of health insurance limits hepatitis C patients' in U.S. access to latest antiviral therapy
Thursday, February 24, 2011 - 10:30
in Health & Medicine
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications.